Literature DB >> 21243572

Factors affecting morbidity and mortality in flail chest: comparison of anterior and lateral location.

D Kilic1, A Findikcioglu, S Akin, T H Akay, E Kupeli, A Aribogan, A Hatipoglu.   

Abstract

OBJECTIVE: Flail chest is most often accompanied by significant underlying pulmonary parenchymal injuries and may constitute a life-threatening thoracic injury. In this study we evaluated the treatment modalities for flail chest depending on the effect of trauma localization on mortality and morbidity.
METHODS: Between 2003 and 2008, 23 patients (20 males/3 females) were treated for flail chest. Location of the trauma in the chest wall, mechanical ventilation support, prognosis and injury severity score (ISS) were recorded for all patients. Mechanical ventilation support was given in 14 patients (60.8 %), and 12 of these 14 patients required subsequent tracheostomy. Internal fixation was used in 3 patients.
RESULTS: The major cause of flail chest was a car crash in 18 of 23 patients (76 %). Median ISS was 62.8 for all patients. The patients with flail chest who had bilateral costochondral separation (anterior chest location) (group I, n = 10) had a significantly higher ISS than those with single-side posterolateral flail chest (group II, n = 13; ISS: 70/55; P = 0.02). The need for mechanical ventilation support was also higher in the group with bilateral costochondral separation. Morbidity was higher in group I than in group II ( P = 0.198), and mortality was also significantly higher in group I ( P = 0.08). Patients with a cranial trauma and flail chest had a higher mortality (19 %) than patients with only flail chest (no mortality). The mean ISS was 75 for patients with cranial trauma and flail chest and 55.7 ( P = 0.001) for patients with only flail chest. Sepsis and subarachnoid bleeding were the major causes of mortality. The mean ISS was 54.5 for patients under the age of 55 (n = 14) whereas it was 69.4 in those aged 55 and over (n = 9; P = 0.034). Mortality in the older group was also higher (33 % versus 7 %; P = 0.02).
CONCLUSION: Early intubation and mechanical ventilation is of paramount importance in patients with flail chest. However, prolonged mechanical ventilation is associated with a poor outcome. Tracheotomy and frequent flexible bronchoscopy are an effective pulmonary toilet. Advanced age was a major risk factor for flail chest trauma mortality, together with the severity of the injury. When cranial trauma was accompanied by flail chest, mortality and morbidity rates increased. Bilateral costochondral separation also increased the risk of morbidity and the need for mechanical ventilation in patients with flail chest. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2011        PMID: 21243572     DOI: 10.1055/s-0030-1250597

Source DB:  PubMed          Journal:  Thorac Cardiovasc Surg        ISSN: 0171-6425            Impact factor:   1.827


  4 in total

1.  Operative Stabilization of Chest Wall Trauma: Single-Center Report of Initial Management and Long-Term Outcome.

Authors:  Christian Michelitsch; Yves Pascal Acklin; Gabriela Hässig; Christoph Sommer; Markus Furrer
Journal:  World J Surg       Date:  2018-12       Impact factor: 3.352

2.  [Bony injuries of the thoracic cage in multiple trauma : Incidence, concomitant injuries, course and outcome].

Authors:  S Schulz-Drost; P Oppel; S Grupp; S Krinner; A Langenbach; R Lefering; A Mauerer
Journal:  Unfallchirurg       Date:  2016-12       Impact factor: 1.000

3.  The modified Ravitch approach for the management of severe anterior flail chest with bilateral sternochondral dislocations: a case report.

Authors:  Gabriel Estremera; Ellen Chieko Omi; Eduardo Smith-Singares
Journal:  Surg Case Rep       Date:  2018-01-19

4.  Evaluation of Lung Contusion, Associated Injuries, and Outcome in a Major Trauma Center in Shiraz, Southern Iran.

Authors:  Parviz Mardani; Mohammad Moayedi Rad; Shahram Paydar; Armin Amirian; Reza Shahriarirad; Amirhossein Erfani; Keivan Ranjbar
Journal:  Emerg Med Int       Date:  2021-04-22       Impact factor: 1.112

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.